當前位置：首頁 SCI期刊 SCIE期刊醫(yī)學中科院4區(qū) JCRQ4 期刊介紹(非官網(wǎng))

Revista Brasileira De Farmacognosia-brazilian Journal Of PharmacognosySCIE

國際簡稱：REV BRAS FARMACOGN 參考譯名：Revista Brasileira De Farmacognosia-巴西生藥學雜志

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q4

基本信息：: ISSN：0102-695X; E-ISSN：1981-528X; 是否OA：開放; 是否預警：否; TOP期刊：否

出版信息：: 出版地區(qū)：BRAZIL; 出版商：Springer International Publishing; 出版語言：Portuguese、English; 出版周期：6 issues per year; 出版年份：2015; 研究方向：CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY

評價信息：: 影響因子：1.4; H-index：37; CiteScore指數(shù)：2.6; SJR指數(shù)：0.303; SNIP指數(shù)：0.443

發(fā)文數(shù)據(jù)：: Gold OA文章占比：9.60%; 研究類文章占比：80.54%; 年發(fā)文量：149; 自引率：0.125; 開源占比：0.0485; 出版撤稿占比：0; 出版國人文章占比：0.11; OA被引用占比：0.9258...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Revista Brasileira De Farmacognosia-brazilian Journal Of Pharmacognosy期刊介紹

The Brazilian Journal of Pharmacognosy is a scientific journal edited and published by the Brazilian Society of Pharmacognosy, an association that brings together researchers, students and professionals who study and investigate the physical, chemical and biological drugs, especially those of vegetable origin, substances isolated and such as the potential source of drugs of natural origin. It is available in printed form for its members and subscribers and openly on the Internet in all your numbers and content. The articles published are original research contributions. To evaluate the work use is made of international standards and is held by the ad hoc advisers, which reflects the quality and credibility of the journal. The BJP is published since 1986.

期刊簡介Revista Brasileira De Farmacognosia-brazilian Journal Of Pharmacognosy期刊介紹

《Revista Brasileira De Farmacognosia-brazilian Journal Of Pharmacognosy》自2015出版以來，是一本醫(yī)學優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學研究結(jié)果，并為醫(yī)學各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進醫(yī)學領(lǐng)域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學領(lǐng)域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關(guān)注點：

預計審稿時間：
醫(yī)學
CHEMISTRY, MEDICINAL
SCIE
中科院4區(qū)
非預警

Cite Score數(shù)據(jù)（2024年最新版）Revista Brasileira De Farmacognosia-brazilian Journal Of Pharmacognosy Cite Score數(shù)據(jù)

CiteScore：2.6
SJR：0.303
SNIP：0.443

學科類別	分區(qū)	排名	百分位
大類：Pharmacology, Toxicology and Pharmaceutics 小類：General Pharmacology, Toxicology and Pharmaceutics	Q2	30 / 80	63%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Revista Brasileira De Farmacognosia-brazilian Journal Of Pharmacognosy 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學科	分區(qū)	小類學科	分區(qū)
醫(yī)學	4區(qū)	CHEMISTRY, MEDICINAL 藥物化學 PHARMACOLOGY & PHARMACY 藥學	4區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運用科學計量學方法對國際、國內(nèi)學術(shù)期刊依據(jù)影響力進行等級劃分的期刊評價標準。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構(gòu)的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Revista Brasileira De Farmacognosia-brazilian Journal Of Pharmacognosy JCR分區(qū)

2023-2024 年最新版

按JIF指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：CHEMISTRY, MEDICINAL	SCIE	Q4	62 / 72	14.6%
學科：PHARMACOLOGY & PHARMACY	SCIE	Q4	275 / 354	22.5%

按JCI指標學科分區(qū)	收錄子集	分區(qū)	排名	百分位
學科：CHEMISTRY, MEDICINAL	SCIE	Q4	62 / 72	14.58%
學科：PHARMACOLOGY & PHARMACY	SCIE	Q4	286 / 354	19.35%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學術(shù)文獻質(zhì)量進行評估。不同學科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計

國家/地區(qū)數(shù)量
Brazil141
CHINA MAINLAND46
Mexico24
Egypt16
USA15
South Korea10
Saudi Arabia9
Thailand9
Pakistan8
Argentina7

本刊中國學者近年發(fā)表論文

1、Anti-hepatic Fibrosis Potential of Ailanthone, A Quassinoid Isolated from Ailanthus altissima
Author: Li, Xiang; Zhao, Qianqian; Liu, Jincai; Li, Yao; Xie, Yanhua; Hu, Yin; Wang, Siwang

Journal: REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY. 2023; Vol. 33, Issue 1, pp. 144-152. DOI: 10.1007/s43450-022-00340-z
2、Liensinine, an Isoquinoline-Type Alkaloid in Lotus Seeds, Suppressed TGF-beta1-Induced Proliferation and Migration in Human Tenon Capsule Fibroblast Cells Through MAP3K7 Gene
Author: Chen, Xu; Zhao, Haixia; Kang, Xin; Tai, Xue; Guo, Wenqi; Shen, Ying

Journal: REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY. 2023; Vol. 33, Issue 1, pp. 128-136. DOI: 10.1007/s43450-022-00334-x
3、Hyperoside Inhibits Endometrial Fibrosis and Inflammation by Targeting TGF-beta/Smad3 Signaling in Intrauterine Adhesion Rats
Author: Zhu, Zhengyan; Song, Yu; Chen, Xuemei; Huang, Huan; Xu, Yuanping; Zhao, Lin

Journal: REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY. 2023; Vol. 33, Issue 1, pp. 89-94. DOI: 10.1007/s43450-022-00283-5
4、Protective Effect of Raspberry Ketone on Deep Vein Thrombosis and the Molecular Mechanism
Author: Zhang, Dalin; Lin, Shusen; Yang, Yujie; Wang, Hecheng

Journal: REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY. 2023; Vol. 33, Issue 1, pp. 116-127. DOI: 10.1007/s43450-022-00320-3
5、Protective Effect of Hyperoside Against Adenine-Induced Oligoasthenospermia in Mice
Author: Dong, Aiguo; Dong, Huidong; He, Hui; Dong, Ailing; Yan, Juanjuan; Huo, Junfeng

Journal: REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY. 2023; Vol. 33, Issue 1, pp. 137-143. DOI: 10.1007/s43450-022-00336-9
6、A Double-Edged Sword: Focusing on Potential Drug-to-Drug Interactions of Quercetin
Author: Ding, Kaixi; Jia, Huanan; Jiang, Wei; Qin, Yangzhen; Wang, Yu; Lei, Ming

Journal: REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY. 2023; Vol. 33, Issue 3, pp. 502-513. DOI: 10.1007/s43450-022-00347-6
7、Trilobatin Ameliorates Inflammatory Response by Regulating the miR375-Mediated Fatty Acid Binding Protein 4 Expression in Adipocytes
Author: Li, Xingan; Wu, Yucui; Jiang, Xiaoqing; Yin, Fei; Yin, Li; Liu, Jianhui

Journal: REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY. 2023; Vol. 33, Issue 1, pp. 214-221. DOI: 10.1007/s43450-022-00356-5
8、Pinosylvin Inhibits Esophageal Squamous Cell Carcinoma Migration and Invasion by Regulating STX6/ITGA3/VASP Pathway
Author: Du, Jin; Zhao, Yang; Hu, Dinghui; Li, Hang; Gao, Lei; Xing, Xuemei; Shi, Kaihu

Journal: REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY. 2023; Vol. 33, Issue 1, pp. 173-181. DOI: 10.1007/s43450-022-00354-7